Therapeutics

Tools

Back to the Top
Search By Attributes

Search Results

Name Synonyms FDA Status Company Target Type Therapy Type Approved
For
E2511 Alzheimer's Disease (Phase 1) Eisai Co., Ltd. Cholinergic System Small Molecule
SUVN-G3031 Samelisant,
17v
Alzheimer's Disease (Phase 1) Suven Life Sciences Ltd Cholinergic System, Other Neurotransmitters Small Molecule